August 21, 2019Open Access
Neoantigen quality, not quantity
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Prioritizing expressed clonal neoantigens in genes required for cancer cell survival may reduce the likelihood of resistance to neoantigen therapies.
Cite This Study
McGranahan et al. (Wed,) studied this question.